Plasmin-α2-antiplasmin complex
Open-knowledge reference entry
Plasmin-α2-antiplasmin complex (PAP) is a 1:1 irreversibly formed inactive complex of the enzyme plasmin and its inhibitor α2-antiplasmin. It is a marker of the activity of the fibrinolytic system and a marker of net activation of fibrinolysis. Excess of the PAP complex can lead to abnormal bleeding due to enhanced clot lysis leading to a hyperfibrinolytic state. The PAP complex can be useful in the determining the prognosis of a clot, but it is limited because it is measured using ELISA.
Various uses of PAP as a marker
Low PAP levels can be indicative that patients with a past myocardial infarction have a higher risk of another coronary event within the following 2 years. Specifically, when PAP levels are less than 100 ng/ml there was an associated 2.2-fold increase in the risk for another coronary event. When the cut off is less than 100 there is a 5-fold increase in risk. This marker is useful in the clinical setting as a potential way to identify patients that are at higher risk. However, there was not a significant difference between the PAP levels of patients that were on anticoagulative therapy versus patients that were not on anticoagulative therapy. PAP is an independent marker for the risk of another coronary event post-MI, as the risk analysis remained constant when confounding factors (e.g. age, sex, BMI, smoking history, etc.) were controlled for.
This brief starts where responsible research should: with the source description of “Plasmin-α2-antiplasmin complex” as open-knowledge reference entry. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as open-knowledge reference entry. Its deeper value depends on whether names, dates, institutions and citations support that framing.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Aug 30, 2026. The linked authority identifier is Q111938912. None of the 0 selected statements returned an explicit reference.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Plasmin-α2-antiplasmin complex”, its source revision and the description used here.
- Expand the search: follow Plasmin-α2-antiplasmin complex primary sources, Plasmin-α2-antiplasmin complex archive and Plasmin-α2-antiplasmin research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Plasmin-α2-antiplasmin complex”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Plasmin-α2-antiplasmin complex” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.